OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
Dnyaneshwar Kalyane, Nidhi Raval, Rahul Maheshwari, et al.
Materials Science and Engineering C (2019) Vol. 98, pp. 1252-1276
Closed Access | Times Cited: 714

Showing 1-25 of 714 citing articles:

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao, Yunxiang Zhou, Lihong Liu, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 1016

A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives
Peng Liu, Guiliang Chen, Jingchen Zhang
Molecules (2022) Vol. 27, Iss. 4, pp. 1372-1372
Open Access | Times Cited: 718

Cellular uptake and retention of nanoparticles: Insights on particle properties and interaction with cellular components
Robin Augustine, Anwarul Hasan, Rosita Primavera, et al.
Materials Today Communications (2020) Vol. 25, pp. 101692-101692
Open Access | Times Cited: 369

Nanomedicine in cancer therapy
Dahua Fan, Yongkai Cao, Meiqun Cao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 282

Tumor-Targeted Cascade Nanoreactor Based on Metal–Organic Frameworks for Synergistic Ferroptosis–Starvation Anticancer Therapy
Xiuyan Wan, Liqun Song, Wei Pan, et al.
ACS Nano (2020) Vol. 14, Iss. 9, pp. 11017-11028
Closed Access | Times Cited: 263

Bioorthogonal Chemistry and Its Applications
Robert E. Bird, S. A. Lemmel, Xiang Yu, et al.
Bioconjugate Chemistry (2021) Vol. 32, Iss. 12, pp. 2457-2479
Open Access | Times Cited: 246

Emerging Applications of Nanotechnology in Healthcare and Medicine
Shiza Malik, Khalid Muhammad, Yasir Waheed
Molecules (2023) Vol. 28, Iss. 18, pp. 6624-6624
Open Access | Times Cited: 213

Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications
Lei Duan, Yang Li, Juan Jin, et al.
Theranostics (2019) Vol. 10, Iss. 2, pp. 462-483
Open Access | Times Cited: 211

Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation
Guorong Hu, Mengfei Guo, Juanjuan Xu, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 197

Exosomes and Nanoengineering: A Match Made for Precision Therapeutics
Phuong H.L. Tran, Dongxi Xiang, Thao T.D. Tran, et al.
Advanced Materials (2019) Vol. 32, Iss. 18
Open Access | Times Cited: 189

Gene Therapy in Cancer Treatment: Why Go Nano?
Catarina Roma‐Rodrigues, Lorenzo Rivas-García, Pedro V. Baptista, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 233-233
Open Access | Times Cited: 175

Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites
Jun Cao, Dennis Huang, Nicholas A. Peppas
Advanced Drug Delivery Reviews (2020) Vol. 167, pp. 170-188
Closed Access | Times Cited: 158

Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
Zeinab Nouri, Sajad Fakhri, Keyvan Nouri, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2276-2276
Open Access | Times Cited: 154

Immunogenic Hybrid Nanovesicles of Liposomes and Tumor-Derived Nanovesicles for Cancer Immunochemotherapy
Mei Hu, Jianyu Zhang, Li Kong, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 3123-3138
Closed Access | Times Cited: 131

Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms
Yixuan Zi, Kaiyun Yang, Jianhua He, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114449-114449
Closed Access | Times Cited: 125

Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review
Lei Xin, Jinfang Gao, Ziliang Zheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 115

Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system
Hui Liu, Yuyan Su, Xinchi Jiang, et al.
Drug Delivery and Translational Research (2022) Vol. 13, Iss. 3, pp. 716-737
Open Access | Times Cited: 108

Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect
Dong Huang, Lingna Sun, Leaf Huang, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 124-124
Open Access | Times Cited: 104

Cancer nanomedicine: a review of nano-therapeutics and challenges ahead
M. Joyce Nirmala, Uma Kizhuveetil, Athira Johnson, et al.
RSC Advances (2023) Vol. 13, Iss. 13, pp. 8606-8629
Open Access | Times Cited: 104

Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect
Victor Ejigah, Oluwanifemi Owoseni, Perpetue Bataille-Backer, et al.
Polymers (2022) Vol. 14, Iss. 13, pp. 2601-2601
Open Access | Times Cited: 101

Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii Folium: Integration of herbal medicine, enzyme engineering, and nanotechnology
Yi Lu, Qiulan Luo, Xiaobin Jia, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 3, pp. 239-254
Open Access | Times Cited: 100

Cancer Therapy by Silver Nanoparticles: Fiction or Reality?
Dávid Kovács, Nóra Igaz, Mohana Krishna Gopisetty, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 839-839
Open Access | Times Cited: 98

An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment
Majid Sharifi, William C. Cho, Asal Ansariesfahani, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2868-2868
Open Access | Times Cited: 89

Page 1 - Next Page

Scroll to top